TABLE 4.
Metabolites or lipids | AUC | 95% CI | P Value | SE |
PE (40:7e); PE (18:1e/22:6) | 0.92 | 0.84–1.00 | 9.20E-05 | 0.04 |
Cer-NS (d40:2); Cer-NS (d18:1/22:1) | 0.90 | 0.80–1.00 | 2.05E-04 | 0.05 |
DAG (44:5e); DAG (22:3e/22:2) | 0.88 | 0.77–0.99 | 4.42E-04 | 0.06 |
PE (38:7e); PE (16:1e/22:6) | 0.84 | 0.71–0.98 | 1.46E-03 | 0.07 |
PE (40:6); PE (18:0–22:6) | 0.84 | 0.70–0.98 | 1.64E-03 | 0.07 |
L-Saccharopine | 0.84 | 0.67–1.00 | 1.46E-03 | 0.09 |
PC (40:6); PC (18:0–22:6) | 0.83 | 0.69–0.96 | 2.56E-03 | 0.07 |
N-Acetylmannosamine | 0.83 | 0.67–0.98 | 2.56E-03 | 0.08 |
Sphinganine (25:0) | 0.82 | 0.69–0.96 | 2.85E-03 | 0.07 |
9-Trans-Palmitelaidic acid | 0.81 | 0.67–0.95 | 4.36E-03 | 0.07 |
Cer-NS (d42:4); Cer-NS (d22:3/20:1) | 0.80 | 0.65–0.96 | 4.84E-03 | 0.08 |
Citramalic acid | 0.80 | 0.63–0.98 | 4.84E-03 | 0.09 |
AUC, area under the curve; 95% CI, 95% confidence interval; SE, standard error; PE, phosphatidylethanolamine; Cer-NS, ceramide non-hydroxyfatty acid-sphingosine; DAG, diacylglycerol; PC, phosphatidylcholine.